https://www.selleckchem.com/pr....oducts/edralbrutinib
med the results of the primary analyses. Drug-coated balloon angioplasty was superior to standard angioplasty for the treatment of stenotic lesions in dysfunctional hemodialysis arteriovenous fistulas during the 6 months after the procedure and was noninferior with respect to access circuit-related serious adverse events within 30 days. (Funded by Medtronic; IN.PACT AV Access Study ClinicalTrials.gov number, NCT03041467.). Drug-coated balloon angioplasty was superior to standard angioplasty for the treatment of stenotic lesions in
Like
Comment
Share
